Publications 2024

Gerdtsson A, Negaard HFS, Almås B, Bergdahl AG, Cohn-Cedermark G, Glimelius I, Halvorsen D, Haugnes HS, Hedlund A, Hellström M, Holmberg G, Karlsdóttir Á, Kjellman A, Larsen SM, Thor A, Wahlqvist R, Ståhl O, Tandstad T (2024)
Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
BJU Int, 133 (6), 717-724
DOI 10.1111/bju.16289, PubMed 38293778

Thor A, Negaard HFS, Grenabo Bergdahl A, Almås B, Melsen Larsen S, Lundgren PO, Gerdtsson A, Halvorsen D, Johannsdottir B, Jansson AK, Hellström M, Wahlqvist R, Langberg CW, Hedlund A, Akre O, Glimelius I, Ståhl O, Haugnes HS, Cohn-Cedermark G, Kjellman A, Tandstad T (2024)
Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience
Eur Urol Open Sci, 65, 13-19
DOI 10.1016/j.euros.2024.05.006, PubMed 38966804

Vedeld HM, Pharo H, Sørbø AK, Brandt-Winge S, Five MB, Jeanmougin M, Guldberg P, Wahlqvist R, Lind GE (2024)
Distinct longitudinal patterns of urine tumor DNA in patients undergoing surveillance for bladder cancer
Mol Oncol, 18 (11), 2684-2695
DOI 10.1002/1878-0261.13639, PubMed 38720532

Publications 2023

Gerdtsson A, Torisson G, Thor A, Grenabo Bergdahl A, Almås B, Håkansson U, Törnblom M, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Haugnes HS, Larsen SM, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2023)
Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
BJU Int, 132 (3), 329-336
DOI 10.1111/bju.16040, PubMed 37129962

Publications 2022

Pharo HD, Jeanmougin M, Ager-Wick E, Vedeld HM, Sørbø AK, Dahl C, Larsen LK, Honne H, Brandt-Winge S, Five MB, Monteiro-Reis S, Henrique R, Jeronimo C, Steven K, Wahlqvist R, Guldberg P, Lind GE (2022)
BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patients
Clin Epigenetics, 14 (1), 115
DOI 10.1186/s13148-022-01335-2, PubMed 36115961

Publications 2021

Gerdtsson A, Thor A, Grenabo Bergdahl A, Almås B, Håkansson U, Törnblom M, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Sagstuen Haugnes H, Engen Andreassen K, Melsen Larsen S, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2021)
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
Eur Urol Oncol, 5 (2), 235-243
DOI 10.1016/j.euo.2021.02.002, PubMed 33750683

Publications 2019

Gerdtsson A, Håkansson U, Törnblom M, Jancke G, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Haugnes HS, Andreassen KE, Larsen SM, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2019)
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group
Eur Urol Oncol, 3 (3), 382-389
DOI 10.1016/j.euo.2019.08.002, PubMed 31506250

Publications 2016

Andreassen BK, Aagnes B, Gislefoss R, Andreassen M, Wahlqvist R (2016)
Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014
BMC Cancer, 16 (1), 799
DOI 10.1186/s12885-016-2832-x, PubMed 27737647

Tandstad T, Ståhl O, Dahl O, Haugnes HS, Håkansson U, Karlsdottir Å, Kjellman A, Langberg CW, Laurell A, Oldenburg J, Solberg A, Söderström K, Stierner U, Cavallin-Ståhl E, Wahlqvist R, Wall N, Cohn-Cedermark G, SWENOTECA (2016)
Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)
Ann Oncol, 27 (7), 1299-304
DOI 10.1093/annonc/mdw164, PubMed 27052649

Publications 2015

Tandstad T, Ståhl O, Håkansson U, Wahlqvist R, Klepp O, Cavallin-Ståhl E, Cohn-Cedermark G, SWENOTECA (2015)
The SWENOTECA group: A good example of continuous binational and multidisciplinary collaboration for patients with testicular cancer in Sweden and Norway
Scand J Urol, 50 (1), 9-13
DOI 10.3109/21681805.2015.1059360, PubMed 26116316

Publications 2011

Malmström PU, Grabe M, Haug ES, Hellström P, Hermann GG, Mogensen K, Raitanen M, Wahlqvist R (2011)
Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance
Scand J Urol Nephrol, 46 (2), 108-16
DOI 10.3109/00365599.2011.633279, PubMed 22087730

Olofsson SE, Tandstad T, Jerkeman M, Dahl O, Ståhl O, Klepp O, Bremnes RM, Cohn-Cedermark G, Langberg CW, Laurell A, Solberg A, Stierner U, Wahlqvist R, Wijkström H, Anderson H, Cavallin-Ståhl E (2011)
Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group
J Clin Oncol, 29 (15), 2032-9
DOI 10.1200/JCO.2010.29.1278, PubMed 21482994

Rosenblatt R, Sherif A, Rintala E, Wahlqvist R, Ullén A, Nilsson S, Malmström PU, Nordic Urothelial Cancer Group (2011)
Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer
Eur Urol, 61 (6), 1229-38
DOI 10.1016/j.eururo.2011.12.010, PubMed 22189383

Publications 2010

Kvåle R, Møller B, Angelsen A, Dahl O, Fosså SD, Halvorsen OJ, Hoem L, Solberg A, Wahlqvist R, Bray F (2010)
Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007
Cancer Epidemiol, 34 (4), 359-67
DOI 10.1016/j.canep.2010.04.017, PubMed 20627840

Røtterud R, Malmström PU, Wahlqvist R, Taskén KA (2010)
The star chart to Ta bladder cancer: an unsophisticated analysis of two-dimensional gel electrophoresis proteome maps
Scand J Urol Nephrol, 44 (2), 76-83
DOI 10.3109/00365590903510729, PubMed 20059407

Publications 2009

Oldenburg J, Wahlqvist R, Fosså SD (2009)
Late relapse of germ cell tumors
World J Urol, 27 (4), 493-500
DOI 10.1007/s00345-009-0411-3, PubMed 19373473

Publications 2008

Kvåle R, Møller B, Wahlqvist R, Fosså SD, Berner A, Busch C, Kyrdalen AE, Svindland A, Viset T, Halvorsen OJ (2008)
Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study
BJU Int, 103 (12), 1647-54
DOI 10.1111/j.1464-410X.2008.08255.x, PubMed 19154461

Publications 2007

Cunderlíková B, Wahlqvist R, Berner A, Vasovic V, Warloe T, Nesland JM, Peng Q (2007)
Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples
Cytopathology, 18 (2), 87-95
DOI 10.1111/j.1365-2303.2007.00436.x, PubMed 17397493

Kvåle R, Auvinen A, Adami HO, Klint A, Hernes E, Møller B, Pukkala E, Storm HH, Tryggvadottir L, Tretli S, Wahlqvist R, Weiderpass E, Bray F (2007)
Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries
J Natl Cancer Inst, 99 (24), 1881-7
DOI 10.1093/jnci/djm249, PubMed 18073376

Publications 2006

Fosså SD, Karlsen S, Wahlqvist R (2006)
Prostatakreft: til pasienter, pårørende og andre interesserte
In Kreftinfo, Den norske kreftforening, Oslo, 42 s.
BIBSYS 06036579x

Kvåle R, Skarre E, Tønne A, Kyrdalen AE, Norstein J, Angelsen A, Wahlqvist R, Fosså SD (2006)
[Curative treatment of prostatic cancer in Norway in 1998 and 2001]
Tidsskr Nor Laegeforen, 126 (7), 912-6
PubMed 16554883

Publications 2005

Fosså SD, Wahlqvist R (2005)
[Radical treatment of prostatic cancer in Norway]
Tidsskr Nor Laegeforen, 125 (20), 2834; author reply 2834-5
PubMed 16244698

Publications 2004

Kvåle R, Fosså SD, Halvorsen OJ, Kyrdalen AE, Norstein J, Wahlqvist R (2004)
Kurativ behandling av prostatacancer i Norge 1997-2001: en analyse basert på data innsamlet av Kreftregisteret
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2004, Abstrakt 60
BIBSYS 052031810

Kvåle R, Fosså SD, Kyrdalen AE, Norstein J, Halvorsen OJ, Wahlqvist R (2004)
Prostatakreft i Norge. Insidens, dødelighet og behandling: en deskriptiv analyse av data fra Kreftregisteret
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2004, Abstrakt 61
BIBSYS 052031896

Wahlqvist R, Kvåle R, Kyrdalen AE, Halvorsen OJ, Norstein J, Fosså SD (2004)
Utvidet registrering av prostatakreft i Norge
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2004, Abstrakt 53
BIBSYS 05203268x

Publications 2003

Karlsen SJ, Wahlqvist R, Eri LM, Angelsen A (2003)
Prostatakreft: feilinformasjon og begrepsforvirring
In Dagens medisin, Dagens medisin, Oslo, (2003)7, s.Kronikk og debatt
BIBSYS 041704622

Wahlqvist R, Fosså SD, Kyrdalen AE, Strand TE, Skarre E, Norstein J (2003)
Nasjonalt program for prostatacancer (NPPC): målsetting, oppstart og de første erfaringer
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2003, Abstrakt 47
BIBSYS 041735668

Publications 2002

Nilsen F, Wahlqvist R (2002)
Uretra ruptur og penis fraktur hos ung mann ved coitus
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2002, Abstrakt 65
BIBSYS 031411916

Publications 2000

Wahlqvist R (2000)
Ultrastructure of the accessory sex glands of the male rat under various conditions: an electron microscopic study of young adult rats, of aged rats and of rats influenced by surgical castration and by agonadotropin releasing hormone agonist
Department of Oral Biology, Division of Anatomy, Dental Faculty, University of Oslo, Oslo, 1 b. (flere pag.)
BIBSYS 000213128, ISBN 82-995376-0-6

Publications 1998

Hellsten S, Rintala E, Wahlqvist R, Malmström PU (1998)
Nordic prospective trials of radical cystectomy and neoadjuvant chemotherapy. The Nordic Cooperative Bladder Cancer Study Group
Eur Urol, 33 Suppl 4, 35-8
DOI 10.1159/000052263, PubMed 9615209

Publications 1997

Ogreid P, Wahlqvist R (1997)
[Laser treatment of benign prostatic hyperplasia]
Nord Med, 112 (3), 89-92
PubMed 9190566

Publications 1996

Eri LM, Wahlqvist R, Tveter KJ (1996)
[Diagnosis and treatment of benign prostatic hyperplasia in general practice. Norwegian Medical Society]
Tidsskr Nor Laegeforen, 116 (27), 3240-4
PubMed 9011979

Malmström PU, Rintala E, Wahlqvist R, Hellström P, Hellsten S, Hannisdal E (1996)
Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group
J Urol, 155 (6), 1903-6
DOI 10.1016/S0022-5347(01)66042-7, PubMed 8618283

Wahlqvist R, Dahl E, Tveter KJ (1996)
Scanning electron microscopy of the accessory sex glands of the adult male rat
Scanning Microsc, 10 (4), 1143-54
PubMed 9854859

Wahlqvist R, Dahl E, Tveter KJ (1996)
Effects of castration upon the morphology of the accessory sex organs of the male rat--a scanning electron microscopy study
Scanning Microsc, 10 (4), 1155-62
PubMed 9854860

Publications 1990

Wahlqvist R (1990)
[Insertion of suprapubic bladder catheter]
Tidsskr Nor Laegeforen, 110 (1), 58
PubMed 2300939

Publications 1988

Hem E, Wahlqvist R, Sivertsen S, Tveter K (1988)
[Uretero-renoscopy. Our initial experience]
Tidsskr Nor Laegeforen, 108 (24), 1898-901
PubMed 3206400

Publications 1987

Ruud TE, Aasen AO, Stadaas JO, Wahlqvist R, Tveter K, Osnes M, Skjennald A (1987)
[Extracorporeal shock waves. A new alternative in the treatment of bile duct stones]
Tidsskr Nor Laegeforen, 107 (13), 1134-6
PubMed 3603472

Ruud TE, Aasen AO, Stadaas JO, Wahlqvist R, Tveter K, Osnes M, Skjennald A (1987)
[Extracorporeal shock waves--a new alternative in the treatment of gallstones]
Nord Med, 102 (12), 343-6
PubMed 3697056

Publications 1984

Fosså SD, Telhaug R, Wahlqvist R (1984)
[Spontaneous remission of metastases from renal cancer]
Tidsskr Nor Laegeforen, 104 (8), 583-5
PubMed 6719422